Li J, Hui N, Zhu L
Changhai Hospital, Second Military Medical University, Shanghai.
Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):429-31.
Three ovarian cancer cell lines, NIH: OVCAR-3, 3AO, and AO were used in this study to assess the synergistic effect of TNF-alpha, IFN-gamma and chemotherapeutic drugs (epirubicin, carboplatin, fluorouracil). It was found that NIH: OVCAR-3 and 3AO cells were resistant to the individual treatment with TNF-alpha and IFN-gamma, while AO cells were sensitive to TNF-alpha but not to INF-gamma. Epirubicin and TNF-alpha were the two major cytotoxic agents to NIH: OVCAR-3. 3AO cells were susceptible to epirubicin, 5-Fu, TNF-alpha and IFN-gamma, while AO cells were sensitive to TNF and epirubicin. Carboplatin did not show any synergistic effect on all these three cell lines when combined with cytokines.
本研究使用了三种卵巢癌细胞系,即美国国立卫生研究院(NIH)的OVCAR-3、3AO和AO细胞系,以评估肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)与化疗药物(表柔比星、卡铂、氟尿嘧啶)的协同作用。研究发现,NIH:OVCAR-3和3AO细胞对TNF-α和IFN-γ的单独治疗具有抗性,而AO细胞对TNF-α敏感,但对INF-γ不敏感。表柔比星和TNF-α是对NIH:OVCAR-3细胞具有主要细胞毒性的两种药物。3AO细胞对表柔比星、5-氟尿嘧啶、TNF-α和IFN-γ敏感,而AO细胞对TNF和表柔比星敏感。卡铂与细胞因子联合使用时,对这三种细胞系均未显示出任何协同作用。